Oleocanthal Ameliorates Amyloid-β Oligomers Toxicity on Astrocytes and Neuronal Cells: In-vitro Studies
Highlights • Oleocanthal rectified Aβo-induced pathological changes in astrocytes and neurons in-vitro. • Oleocanthal reduced astrocytes activation and inflammation associated with Aβ oligomers exposure. • The neuroprotective effect of oleocanthal could be direct and not mediated by astrocytes....
Saved in:
Published in | Neuroscience Vol. 352; pp. 204 - 215 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Ltd
03.06.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Highlights • Oleocanthal rectified Aβo-induced pathological changes in astrocytes and neurons in-vitro. • Oleocanthal reduced astrocytes activation and inflammation associated with Aβ oligomers exposure. • The neuroprotective effect of oleocanthal could be direct and not mediated by astrocytes. |
---|---|
AbstractList | Extra-virgin olive oil (EVOO) has several health promoting effects. Evidence have shown that EVOO attenuates the pathology of amyloid-β (Aβ) and improves cognitive function in experimental animal models, suggesting it's potential to protect and reduce the risk of developing Alzheimer's disease (AD). Available studies have linked this beneficial effect to oleocanthal, one of the active components in EVOO. The effect of oleocanthal against AD pathology has been linked to its ability to attenuate Aβ and tau aggregation in vitro, and enhance Aβ clearance from the brains of wild-type and AD transgenic mice in vivo. However, the ability of oleocanthal to alter the toxic effect of Aβ on brain parenchymal cells is unknown. In the current study, we investigated oleocanthal effect on modulating Aβ oligomers (Aβo) pathological events in neurons and astrocytes. Our findings demonstrated oleocanthal prevented Aβo-induced synaptic proteins, SNAP-25 and PSD-95, down-regulation in neurons, and attenuated Aβo-induced inflammation, glutamine transporter (GLT1) and glucose transporter (GLUT1) down-regulation in astrocytes. Aβo-induced inflammation was characterized by interleukin-6 (IL-6) increase and glial fibrillary acidic protein (GFAP) upregulation that were reduced by oleocanthal. In conclusion, this study provides further evidence to support the protective effect of EVOO-derived phenolic secoiridoid oleocanthal against AD pathology. Highlights • Oleocanthal rectified Aβo-induced pathological changes in astrocytes and neurons in-vitro. • Oleocanthal reduced astrocytes activation and inflammation associated with Aβ oligomers exposure. • The neuroprotective effect of oleocanthal could be direct and not mediated by astrocytes. •Oleocanthal rectified Aβo-induced pathological changes in astrocytes and neurons in vitro.•Oleocanthal reduced astrocyte activation and inflammation associated with Aβ oligomer exposure.•The neuroprotective effect of oleocanthal could be direct and not mediated by astrocytes. Extra-virgin olive oil (EVOO) has several health promoting effects. Evidence have shown that EVOO attenuates the pathology of amyloid-β (Aβ) and improves cognitive function in experimental animal models, suggesting it’s potential to protect and reduce the risk of developing Alzheimer’s disease (AD). Available studies have linked this beneficial effect to oleocanthal, one of the active components in EVOO. The effect of oleocanthal against AD pathology has been linked to its ability to attenuate Aβ and tau aggregation in vitro, and enhance Aβ clearance from the brains of wild-type and AD transgenic mice in vivo. However, the ability of oleocanthal to alter the toxic effect of Aβ on brain parenchymal cells is unknown. In the current study, we investigated oleocanthal effect on modulating Aβ oligomers (Aβo) pathological events in neurons and astrocytes. Our findings demonstrated oleocanthal prevented Aβo-induced synaptic proteins, SNAP-25 and PSD-95, down-regulation in neurons, and attenuated Aβo-induced inflammation, glutamine transporter (GLT1) and glucose transporter (GLUT1) down-regulation in astrocytes. Aβo-induced inflammation was characterized by interleukin-6 (IL-6) increase and glial fibrillary acidic protein (GFAP) upregulation that were reduced by oleocanthal. In conclusion, this study provides further evidence to support the protective effect of EVOO-derived phenolic secoiridoid oleocanthal against AD pathology. |
Author | Batarseh, Yazan S Siddique, Abu Bakar Mohamed, Loqman A Mousa, Youssef M El Sayed, Khalid A Kaddoumi, Amal Al Rihani, Sweilem B |
Author_xml | – sequence: 1 fullname: Batarseh, Yazan S – sequence: 2 fullname: Mohamed, Loqman A – sequence: 3 fullname: Al Rihani, Sweilem B – sequence: 4 fullname: Mousa, Youssef M – sequence: 5 fullname: Siddique, Abu Bakar – sequence: 6 fullname: El Sayed, Khalid A – sequence: 7 fullname: Kaddoumi, Amal |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28392295$$D View this record in MEDLINE/PubMed |
BookMark | eNqNks1OGzEUha0KVALtK1Sj7mfw7_ywQIrSFpBQs4CuLce-Q5w6NrInUee1-iB9JjwKRbQrvLmWfM65V5_vKTrywQNCnwmuCCb1-abysIshaQteQ0UxaSrMKiy6d2hG2oaVjeD8CM0ww3XJBaUn6DSlDc5HcPYendCWdZR2YobWSwdBKz-slSvmW3A2RDVAyvfRBWvKP7-LpbMPYQsxFffhl9V2GIvgi3kaYtDjpFXeFN-nkXwOWYBz6aK48eXeZkVxN-yMhfQBHffKJfj4XM_Qj29f7xfX5e3y6mYxvy214HQoW4HbVvdU9H3XiVXLWM2VNoAV5ZipRgtcC7HqMaNNs-Kkq4HURhCuc2HasDN0ech93K22YDT4ISonH6PdqjjKoKz898XbtXwIeykE5nVX54CLQ4DOiFOE_sVLsJz4y418zV9O_CVmMvPP5k-vu79Y_wLPgi8HAWQGewtRPscYG0EP0gT7tj6X_8VoZ73Vyv2EEdIm7GL-iySJTFRieTdtwrQIpGGYMt6yJ0LJt-c |
CitedBy_id | crossref_primary_10_1016_j_jnutbio_2017_12_006 crossref_primary_10_1111_bcpt_14006 crossref_primary_10_1016_j_ctim_2018_12_003 crossref_primary_10_3390_ijms18112230 crossref_primary_10_3390_molecules24102001 crossref_primary_10_1186_s12868_019_0489_5 crossref_primary_10_1016_j_advms_2022_08_003 crossref_primary_10_1016_j_arcmed_2024_103039 crossref_primary_10_3390_nu13051702 crossref_primary_10_1007_s13668_018_0222_5 crossref_primary_10_3390_ijms21072501 crossref_primary_10_1016_j_ijpharm_2019_118596 crossref_primary_10_1021_acsptsci_0c00166 crossref_primary_10_3390_ijms20246303 crossref_primary_10_3390_foods7060090 crossref_primary_10_3390_molecules23040870 crossref_primary_10_1007_s12035_022_03042_8 crossref_primary_10_1016_j_arr_2024_102210 crossref_primary_10_1016_j_ejpn_2018_11_007 crossref_primary_10_3390_ijms19082329 crossref_primary_10_3390_pharmaceutics11100515 crossref_primary_10_1016_j_expneurol_2020_113248 crossref_primary_10_1038_s41598_021_01752_y crossref_primary_10_3390_ijms25031914 crossref_primary_10_1016_j_neurol_2019_07_017 crossref_primary_10_3390_nu14142998 crossref_primary_10_1017_S095442242100041X crossref_primary_10_3390_nu12020314 crossref_primary_10_1016_j_ejmech_2019_03_009 crossref_primary_10_3389_fnins_2022_952096 crossref_primary_10_3390_ijms242417323 crossref_primary_10_3389_fnagi_2020_617071 crossref_primary_10_1111_bph_14782 crossref_primary_10_3390_molecules28145592 crossref_primary_10_3390_ijms22147366 crossref_primary_10_3390_nu10050570 crossref_primary_10_1080_10408398_2019_1650715 crossref_primary_10_1021_acs_jafc_8b06723 crossref_primary_10_3233_JAD_190223 crossref_primary_10_1021_acs_jafc_8b00561 crossref_primary_10_1016_j_clineuro_2020_105727 crossref_primary_10_3390_cancers11050637 crossref_primary_10_3233_JAD_210595 |
Cites_doi | 10.3390/ijms150712323 10.1038/srep38187 10.1186/1750-1326-9-48 10.1016/j.jalz.2015.02.003 10.1016/j.mrfmmm.2009.08.016 10.1523/JNEUROSCI.5274-12.2013 10.1002/(SICI)1522-2683(19990101)20:4/5<928::AID-ELPS928>3.0.CO;2-Z 10.1016/j.ebiom.2016.03.035 10.1016/j.nbd.2008.02.012 10.1016/j.expneurol.2009.10.013 10.1002/glia.21004 10.1046/j.1471-4159.2000.0751076.x 10.3389/fnsyn.2016.00007 10.1021/cn400024q 10.1016/j.neuint.2016.05.009 10.3390/ijms17030338 10.1523/JNEUROSCI.6357-11.2012 10.1007/s00401-009-0522-3 10.1038/ncomms11761 10.1046/j.1469-7580.2002.00064.x 10.1111/j.1471-4159.2009.06224.x 10.1074/jbc.M407963200 10.1021/bi401606f 10.1016/j.lfs.2012.09.012 10.1038/437045a 10.1073/pnas.82.12.4245 10.3233/JAD-2010-1221 10.1074/jbc.M111.236257 10.4065/80.10.1326 10.1016/j.cbi.2005.10.088 10.2174/156720511794604543 10.1111/j.1742-4658.2010.07568.x 10.1016/j.bbr.2008.02.016 10.31887/DCNS.2009.11.3/mbelanger 10.1152/physrev.2001.81.2.741 10.1371/journal.pone.0155878 10.1007/s12640-014-9468-x 10.1212/WNL.0000000000000328 10.1016/j.taap.2009.07.018 10.1111/j.1471-4159.2007.04533.x 10.1016/j.tiv.2016.12.003 10.1080/15548627.2016.1159375 10.1016/j.neuropharm.2014.01.023 10.1038/nm838 10.1021/acschemneuro.5b00190 10.3389/fphys.2012.00269 10.1016/0006-291X(84)91209-9 10.1016/j.neuint.2016.04.010 |
ContentType | Journal Article |
Copyright | IBRO 2017 IBRO Copyright © 2017 IBRO. Published by Elsevier Ltd. All rights reserved. |
Copyright_xml | – notice: IBRO – notice: 2017 IBRO – notice: Copyright © 2017 IBRO. Published by Elsevier Ltd. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM |
DOI | 10.1016/j.neuroscience.2017.03.059 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1873-7544 |
EndPage | 215 |
ExternalDocumentID | 10_1016_j_neuroscience_2017_03_059 28392295 S0306452217302348 1_s2_0_S0306452217302348 |
Genre | Journal Article |
GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: P20 GM103424 – fundername: NINDS NIH HHS grantid: R15 NS091934 |
GroupedDBID | - 08R 0R 1 1- 123 1B1 1P 1RT 1~. 1~5 29N 4.4 457 4G. 53G 55 5RE 5VS 7-5 71M 8P 9JM AABNK AACTN AADPK AAEDT AAIAV AAIKJ AAKOC AALMO AALRI AAOAW AAQFI AAQXK AAXLA AAXUO ABCQJ ABFLS ABFNM ABFRF ABLJU ABMAC ABPIF ABPTK ABQIS ABTEW ABWYI ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIUM ACRLP ADALY ADBBV ADEZE AEBSH AEFWE AEKER AENEX AEVXI AFCTW AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGWIK AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AZFZN BKOJK BLXMC CS3 DU5 DZ EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FO G- G-2 G-Q GBLVA GJ HMQ HVGLF HZ IHE IPNFZ J1W K KOM L7B M M2V M41 MO0 MOBAO N9A O-L O9- OAUVE OP OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCC SDF SDG SDP SES SEW SNS SPCBC SSN SSZ T5K UNMZH WUQ X X7M Z5R ZGI ZXP --- --K --M -DZ -~X .1- .FO .~1 0R~ 1P~ 8P~ AAEDW ABJNI AXJTR EFLBG FYGXN OP~ ~G- AAXKI AKRWK CGR CUY CVF ECM EIF NPM .55 .GJ AAYXX ADMUD AFJKZ CITATION HZ~ YYP 5PM |
ID | FETCH-LOGICAL-c542t-85088cf25ff995b83364acde0a2403a7c50655bf03277b4196e16d514c16d3cd3 |
IEDL.DBID | .~1 |
ISSN | 0306-4522 |
IngestDate | Tue Sep 17 20:58:18 EDT 2024 Thu Sep 26 17:04:19 EDT 2024 Sat Sep 28 08:39:01 EDT 2024 Fri Feb 23 02:29:42 EST 2024 Thu Aug 18 17:14:44 EDT 2022 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | APP BBB DMSO Extra-virgin olive oil Radioimmunoprecipitation assay IDE Blood brain barrier Insulin-degrading enzyme RIPA Aβ oligomers Interleukin-6 Aβ BSA soluble APPβ Apolipoprotein E Phosphate buffer saline ApoE Amyloid-β ABCA1 Glucose transporter PBS Bovine serum albumin GLUT1 AD GLT1 Alzheimer’s disease Astrocytes Neurons Astrocytes conditioned media Glial fibrillary acidic protein Aβ monomer Soluble APPα Neuroinflammation ACM Oleocanthal Amyloid precursor protein IL-6 GFAP sAPPα EVOO ATP-binding cassette transporter-A1 Glutamate transporter Dimethyl sulfoxide sAPPβ Aβm Aβo neurons oleocanthal neuroinflammation amyloid-β astrocytes |
Language | English |
License | Copyright © 2017 IBRO. Published by Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c542t-85088cf25ff995b83364acde0a2403a7c50655bf03277b4196e16d514c16d3cd3 |
OpenAccessLink | https://europepmc.org/articles/pmc5504696?pdf=render |
PMID | 28392295 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5504696 crossref_primary_10_1016_j_neuroscience_2017_03_059 pubmed_primary_28392295 elsevier_sciencedirect_doi_10_1016_j_neuroscience_2017_03_059 elsevier_clinicalkeyesjournals_1_s2_0_S0306452217302348 |
PublicationCentury | 2000 |
PublicationDate | 2017-06-03 |
PublicationDateYYYYMMDD | 2017-06-03 |
PublicationDate_xml | – month: 06 year: 2017 text: 2017-06-03 day: 03 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Neuroscience |
PublicationTitleAlternate | Neuroscience |
PublicationYear | 2017 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
References | Brown, Tamas, Reglodi, Tizabi (b0070) 2014; 26 Rimmele, Rosenberg (b0210) 2016; 98 Selkoe (b0235) 2008; 192 Danbolt, Furness, Zhou (b0085) 2016; 98 Lasagna-Reeves, Glabe, Kayed (b0135) 2011; 286 Scimemi, Meabon, Woltjer, Sullivan, Diamond, Cook (b0220) 2013; 33 Spuch, Ortolano, Navarro (b0250) 2012; 3 Scotece, Gomez, Conde, Lopez, Gomez-Reino, Lago, Smith, Gualillo (b0225) 2012; 91 Tu, Okamoto, Lipton, Xu (b0255) 2014; 9 Glenner, Wong (b0115) 1984; 122 Benarroch (b0060) 2014; 82 Cobos, del Pozo, Baeyens (b0080) 2007; 102 Li, Zhao, Gao, Wei, Yin, Lau, Chui, Yu (b0145) 2011; 8 Beauchamp, Keast, Morel, Lin, Pika, Han, Lee, Smith, Breslin (b0035) 2005; 437 Son, Cha, Choi, Kang, Choi, Lee, Park, Mook-Jung (b0245) 2016; 12 Pitt, Roth, Lacor, Smith, Blankenship, Velasco, De Felice, Breslin, Klein (b0195) 2009; 240 Nielsen, Mulder, Belien, Musters, Eikelenboom, Veerhuis (b0175) 2010; 58 Narayan, Holmstrom, Kim, Whitcomb, Wilson, St George-Hyslop, Wood, Dobson, Cho, Abramov, Klenerman (b0170) 2014; 53 Antonucci, Corradini, Fossati, Tomasoni, Menna, Matteoli (b0020) 2016; 8 Li, Sperry, Crowe, Trojanowski, Smith, Lee (b0150) 2009; 110 Fernandes, Emerick, Ferreira, Santos, Santos (b0105) 2017; 39 Siow, Xie, Choi, Tsim (b9000) 2005; 157–158 Selkoe (b0230) 2001; 81 Abbott (b0005) 2002; 200 Biedler, Roffler-Tarlov, Schachner, Freedman (b0065) 1978; 38 Murphy, LeVine (b0165) 2010; 19 Qosa, Batarseh, Mohyeldin, El Sayed, Keller, Kaddoumi (b0205) 2015; 6 Masters, Simms, Weinman, Multhaup, McDonald, Beyreuther (b0155) 1985; 82 Sakono, Zako (b0215) 2010; 277 Feng, Hu, Lu, Wang, Du (b0100) 2014; 7 Beglopoulos, Tulloch, Roe, Daumas, Ferrington, Watson, Fan, Hyman, Kelly, Bard, Morris (b0040) 2016; 7 Greber, Lubec, Cairns, Fountoulakis (b0120) 1999; 20 Parkinson, Keast (b0180) 2014; 15 Wyss-Coray, Loike, Brionne, Lu, Anankov, Yan, Silverstein, Husemann (b0265) 2003; 9 Sengupta, Nilson, Kayed (b0240) 2016; 6 Alzheimer's (b0015) 2015; 11 Fuller, Steele, Munch (b0110) 2010; 690 Leuba, Walzer, Vernay, Carnal, Kraftsik, Piotton, Marin, Bouras, Savioz (b0140) 2008; 30 Kayed, Lasagna-Reeves (b0130) 2013; 33 Qosa, Abuasal, Romero, Weksler, Couraud, Keller, Kaddoumi (b0200) 2014; 79 Wahrle, Jiang, Parsadanian, Legleiter, Han, Fryer, Kowalewski, Holtzman (b0260) 2004; 279 Abuznait, Qosa, Busnena, El Sayed, Kaddoumi (b0010) 2013; 4 Belanger, Magistretti (b0045) 2009; 11 Benarroch (b0055) 2005; 80 Busche, Konnerth (b0075) 2016 Perez, Carrero, Gonzalo, Arevalo-Serrano, Sanz-Anquela, Ortega, Rodriguez, Gonzalo-Ruiz (b0190) 2010; 223 Esparza, Wildburger, Jiang, Gangolli, Cairns, Bateman, Brody (b0095) 2016; 6 Batarseh, Duong, Mousa, Al Rihani, Elfakhri, Kaddoumi (b0030) 2016; 17 Bell, Zlokovic (b0050) 2009; 118 Auderset, Cullen, Young (b0025) 2016; 11 Perego, Vanoni, Bossi, Massari, Basudev, Longhi, Pietrini (b0185) 2000; 75 Jung, An, Hong, Kim, Mook-Jung (b0125) 2012; 32 Nielsen (10.1016/j.neuroscience.2017.03.059_b0175) 2010; 58 Perego (10.1016/j.neuroscience.2017.03.059_b0185) 2000; 75 Jung (10.1016/j.neuroscience.2017.03.059_b0125) 2012; 32 Pitt (10.1016/j.neuroscience.2017.03.059_b0195) 2009; 240 Siow (10.1016/j.neuroscience.2017.03.059_b9000) 2005; 157–158 Fernandes (10.1016/j.neuroscience.2017.03.059_b0105) 2017; 39 Glenner (10.1016/j.neuroscience.2017.03.059_b0115) 1984; 122 Li (10.1016/j.neuroscience.2017.03.059_b0145) 2011; 8 Murphy (10.1016/j.neuroscience.2017.03.059_b0165) 2010; 19 Lasagna-Reeves (10.1016/j.neuroscience.2017.03.059_b0135) 2011; 286 Wahrle (10.1016/j.neuroscience.2017.03.059_b0260) 2004; 279 Beauchamp (10.1016/j.neuroscience.2017.03.059_b0035) 2005; 437 Alzheimer's (10.1016/j.neuroscience.2017.03.059_b0015) 2015; 11 Scotece (10.1016/j.neuroscience.2017.03.059_b0225) 2012; 91 Tu (10.1016/j.neuroscience.2017.03.059_b0255) 2014; 9 Leuba (10.1016/j.neuroscience.2017.03.059_b0140) 2008; 30 Benarroch (10.1016/j.neuroscience.2017.03.059_b0060) 2014; 82 Qosa (10.1016/j.neuroscience.2017.03.059_b0205) 2015; 6 Feng (10.1016/j.neuroscience.2017.03.059_b0100) 2014; 7 Parkinson (10.1016/j.neuroscience.2017.03.059_b0180) 2014; 15 Rimmele (10.1016/j.neuroscience.2017.03.059_b0210) 2016; 98 Greber (10.1016/j.neuroscience.2017.03.059_b0120) 1999; 20 Sakono (10.1016/j.neuroscience.2017.03.059_b0215) 2010; 277 Bell (10.1016/j.neuroscience.2017.03.059_b0050) 2009; 118 Qosa (10.1016/j.neuroscience.2017.03.059_b0200) 2014; 79 Biedler (10.1016/j.neuroscience.2017.03.059_b0065) 1978; 38 Perez (10.1016/j.neuroscience.2017.03.059_b0190) 2010; 223 Sengupta (10.1016/j.neuroscience.2017.03.059_b0240) 2016; 6 Beglopoulos (10.1016/j.neuroscience.2017.03.059_b0040) 2016; 7 Narayan (10.1016/j.neuroscience.2017.03.059_b0170) 2014; 53 Benarroch (10.1016/j.neuroscience.2017.03.059_b0055) 2005; 80 Fuller (10.1016/j.neuroscience.2017.03.059_b0110) 2010; 690 Wyss-Coray (10.1016/j.neuroscience.2017.03.059_b0265) 2003; 9 Belanger (10.1016/j.neuroscience.2017.03.059_b0045) 2009; 11 Abuznait (10.1016/j.neuroscience.2017.03.059_b0010) 2013; 4 Brown (10.1016/j.neuroscience.2017.03.059_b0070) 2014; 26 Scimemi (10.1016/j.neuroscience.2017.03.059_b0220) 2013; 33 Cobos (10.1016/j.neuroscience.2017.03.059_b0080) 2007; 102 Son (10.1016/j.neuroscience.2017.03.059_b0245) 2016; 12 Antonucci (10.1016/j.neuroscience.2017.03.059_b0020) 2016; 8 Busche (10.1016/j.neuroscience.2017.03.059_b0075) 2016 Auderset (10.1016/j.neuroscience.2017.03.059_b0025) 2016; 11 Kayed (10.1016/j.neuroscience.2017.03.059_b0130) 2013; 33 Abbott (10.1016/j.neuroscience.2017.03.059_b0005) 2002; 200 Danbolt (10.1016/j.neuroscience.2017.03.059_b0085) 2016; 98 Batarseh (10.1016/j.neuroscience.2017.03.059_b0030) 2016; 17 Esparza (10.1016/j.neuroscience.2017.03.059_b0095) 2016; 6 Masters (10.1016/j.neuroscience.2017.03.059_b0155) 1985; 82 Selkoe (10.1016/j.neuroscience.2017.03.059_b0230) 2001; 81 Selkoe (10.1016/j.neuroscience.2017.03.059_b0235) 2008; 192 Li (10.1016/j.neuroscience.2017.03.059_b0150) 2009; 110 Spuch (10.1016/j.neuroscience.2017.03.059_b0250) 2012; 3 |
References_xml | – volume: 4 start-page: 973 year: 2013 end-page: 982 ident: b0010 article-title: Olive-oil-derived oleocanthal enhances beta-amyloid clearance as a potential neuroprotective mechanism against Alzheimer's disease: in vitro and in vivo studies publication-title: ACS Chem Neurosci contributor: fullname: Kaddoumi – volume: 32 start-page: 3081 year: 2012 end-page: 3087 ident: b0125 article-title: Astrocyte-originated ATP protects Abeta(1–42)-induced impairment of synaptic plasticity publication-title: J Neurosci contributor: fullname: Mook-Jung – volume: 30 start-page: 408 year: 2008 end-page: 419 ident: b0140 article-title: Postsynaptic density protein PSD-95 expression in Alzheimer's disease and okadaic acid induced neuritic retraction publication-title: Neurobiol Dis contributor: fullname: Savioz – volume: 11 start-page: 281 year: 2009 end-page: 295 ident: b0045 article-title: The role of astroglia in neuroprotection publication-title: Dial Clin Neurosci contributor: fullname: Magistretti – volume: 192 start-page: 106 year: 2008 end-page: 113 ident: b0235 article-title: Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior publication-title: Behav Brain Res contributor: fullname: Selkoe – volume: 38 start-page: 3751 year: 1978 end-page: 3757 ident: b0065 article-title: Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones publication-title: Cancer Res contributor: fullname: Freedman – volume: 17 start-page: 338 year: 2016 ident: b0030 article-title: Amyloid-beta and astrocytes interplay in amyloid-beta related disorders publication-title: Int J Mol Sci contributor: fullname: Kaddoumi – volume: 53 start-page: 2442 year: 2014 end-page: 2453 ident: b0170 article-title: Rare individual amyloid-beta oligomers act on astrocytes to initiate neuronal damage publication-title: Biochemistry contributor: fullname: Klenerman – volume: 223 start-page: 410 year: 2010 end-page: 421 ident: b0190 article-title: Soluble oligomeric forms of beta-amyloid (Abeta) peptide stimulate Abeta production via astrogliosis in the rat brain publication-title: Exp Neurol contributor: fullname: Gonzalo-Ruiz – volume: 3 start-page: 269 year: 2012 ident: b0250 article-title: LRP-1 and LRP-2 receptors function in the membrane neuron. Trafficking mechanisms and proteolytic processing in Alzheimer's disease publication-title: Front Physiol contributor: fullname: Navarro – volume: 200 start-page: 629 year: 2002 end-page: 638 ident: b0005 article-title: Astrocyte-endothelial interactions and blood–brain barrier permeability publication-title: J Anat contributor: fullname: Abbott – volume: 11 start-page: 332 year: 2015 end-page: 384 ident: b0015 article-title: 2015 Alzheimer's disease facts and figures publication-title: Alzheimer's Dement contributor: fullname: Alzheimer's – volume: 11 start-page: e0155878 year: 2016 ident: b0025 article-title: Low density lipoprotein-receptor related protein 1 is differentially expressed by neuronal and glial populations in the developing and mature mouse central nervous system publication-title: PLoS One contributor: fullname: Young – volume: 110 start-page: 1339 year: 2009 end-page: 1351 ident: b0150 article-title: Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau publication-title: J Neurochem contributor: fullname: Lee – volume: 240 start-page: 189 year: 2009 end-page: 197 ident: b0195 article-title: Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal publication-title: Toxicol Appl Pharmacol contributor: fullname: Klein – volume: 33 start-page: 5312 year: 2013 end-page: 5318 ident: b0220 article-title: Amyloid-beta1-42 slows clearance of synaptically released glutamate by mislocalizing astrocytic GLT-1 publication-title: J Neurosci contributor: fullname: Cook – volume: 102 start-page: 812 year: 2007 end-page: 825 ident: b0080 article-title: Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells publication-title: J Neurochem contributor: fullname: Baeyens – volume: 75 start-page: 1076 year: 2000 end-page: 1084 ident: b0185 article-title: The GLT-1 and GLAST glutamate transporters are expressed on morphologically distinct astrocytes and regulated by neuronal activity in primary hippocampal cocultures publication-title: J Neurochem contributor: fullname: Pietrini – volume: 98 start-page: 19 year: 2016 end-page: 28 ident: b0210 article-title: GLT-1: the elusive presynaptic glutamate transporter publication-title: Neurochem Int contributor: fullname: Rosenberg – volume: 98 start-page: 29 year: 2016 end-page: 45 ident: b0085 article-title: Neuronal vs glial glutamate uptake: Resolving the conundrum publication-title: Neurochem Int contributor: fullname: Zhou – volume: 8 start-page: 67 year: 2011 end-page: 80 ident: b0145 article-title: Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease publication-title: Curr Alzheimer Res contributor: fullname: Yu – volume: 118 start-page: 103 year: 2009 end-page: 113 ident: b0050 article-title: Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer's disease publication-title: Acta Neuropathol contributor: fullname: Zlokovic – volume: 8 start-page: 7 year: 2016 ident: b0020 article-title: SNAP-25, a known presynaptic protein with emerging postsynaptic functions publication-title: Front Syn Neurosci contributor: fullname: Matteoli – volume: 9 start-page: 48 year: 2014 ident: b0255 article-title: Oligomeric Abeta-induced synaptic dysfunction in Alzheimer's disease publication-title: Mol Neurodegeneration contributor: fullname: Xu – volume: 7 start-page: 549 year: 2014 end-page: 557 ident: b0100 article-title: Effects of APP 5-mer peptide analogue P165 on the synaptic proteins and insulin signal transduction proteins publication-title: Int J Clin Exp Med contributor: fullname: Du – volume: 39 start-page: 84 year: 2017 end-page: 92 ident: b0105 article-title: High concentration of trichlorfon (1mM) disrupts axonal cytoskeleton and decreases the expression of plasticity-related proteins in SH-SY5Y cells publication-title: Toxicol In Vitro contributor: fullname: Santos – volume: 122 start-page: 1131 year: 1984 end-page: 1135 ident: b0115 article-title: Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein publication-title: Biochem Biophys Res Commun contributor: fullname: Wong – volume: 79 start-page: 668 year: 2014 end-page: 678 ident: b0200 article-title: Differences in amyloid-beta clearance across mouse and human blood–brain barrier models: kinetic analysis and mechanistic modeling publication-title: Neuropharmacology contributor: fullname: Kaddoumi – volume: 437 start-page: 45 year: 2005 end-page: 46 ident: b0035 article-title: Phytochemistry: ibuprofen-like activity in extra-virgin olive oil publication-title: Nature contributor: fullname: Breslin – volume: 277 start-page: 1348 year: 2010 end-page: 1358 ident: b0215 article-title: Amyloid oligomers: formation and toxicity of Abeta oligomers publication-title: FEBS J contributor: fullname: Zako – volume: 82 start-page: 4245 year: 1985 end-page: 4249 ident: b0155 article-title: Amyloid plaque core protein in Alzheimer disease and Down syndrome publication-title: Proc Natl Acad Sci USA contributor: fullname: Beyreuther – volume: 286 start-page: 22122 year: 2011 end-page: 22130 ident: b0135 article-title: Amyloid-beta annular protofibrils evade fibrillar fate in Alzheimer disease brain publication-title: J Biol Chem contributor: fullname: Kayed – volume: 6 start-page: 1849 year: 2015 end-page: 1859 ident: b0205 article-title: Oleocanthal enhances amyloid-beta clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model publication-title: ACS Chem Neurosci contributor: fullname: Kaddoumi – volume: 279 start-page: 40987 year: 2004 end-page: 40993 ident: b0260 article-title: ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE publication-title: J Biol Chem contributor: fullname: Holtzman – volume: 157–158 start-page: 423 year: 2005 end-page: 426 ident: b9000 article-title: ATP induces the post-synaptic gene expression in neuron-neuron synapses: Transcriptional regulation of AChE catalytic subunit publication-title: Chem-biol interact contributor: fullname: Tsim – volume: 91 start-page: 1229 year: 2012 end-page: 1235 ident: b0225 article-title: Further evidence for the anti-inflammatory activity of oleocanthal: inhibition of MIP-1alpha and IL-6 in J774 macrophages and in ATDC5 chondrocytes publication-title: Life Sci contributor: fullname: Gualillo – volume: 15 start-page: 12323 year: 2014 end-page: 12334 ident: b0180 article-title: Oleocanthal, a phenolic derived from virgin olive oil: a review of the beneficial effects on inflammatory disease publication-title: Int J Mol Sci contributor: fullname: Keast – volume: 9 start-page: 453 year: 2003 end-page: 457 ident: b0265 article-title: Adult mouse astrocytes degrade amyloid-beta in vitro and in situ publication-title: Nat Med contributor: fullname: Husemann – volume: 7 start-page: 11761 year: 2016 ident: b0040 article-title: Early detection of cryptic memory and glucose uptake deficits in pre-pathological APP mice publication-title: Nat Commun contributor: fullname: Morris – volume: 26 start-page: 230 year: 2014 end-page: 239 ident: b0070 article-title: PACAP protects against inflammatory-mediated toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease publication-title: Neurotox Res contributor: fullname: Tizabi – volume: 12 start-page: 784 year: 2016 end-page: 800 ident: b0245 article-title: Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease publication-title: Autophagy contributor: fullname: Mook-Jung – volume: 81 start-page: 741 year: 2001 end-page: 766 ident: b0230 article-title: Alzheimer's disease: genes, proteins, and therapy publication-title: Physiol Rev contributor: fullname: Selkoe – volume: 690 start-page: 40 year: 2010 end-page: 49 ident: b0110 article-title: Activated astroglia during chronic inflammation in Alzheimer's disease–do they neglect their neurosupportive roles? publication-title: Mutat Res contributor: fullname: Munch – volume: 80 start-page: 1326 year: 2005 end-page: 1338 ident: b0055 article-title: Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system publication-title: Mayo Clin Proc contributor: fullname: Benarroch – start-page: 371 year: 2016 ident: b0075 article-title: Impairments of neural circuit function in Alzheimer's disease publication-title: Philo Trans R Soc Lond Ser B contributor: fullname: Konnerth – volume: 20 start-page: 928 year: 1999 end-page: 934 ident: b0120 article-title: Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease publication-title: Electrophoresis contributor: fullname: Fountoulakis – volume: 6 start-page: 38187 year: 2016 ident: b0095 article-title: Soluble amyloid-beta aggregates from human Alzheimer's disease brains publication-title: Sci Rep contributor: fullname: Brody – volume: 33 start-page: S67 year: 2013 end-page: 78 ident: b0130 article-title: Molecular mechanisms of amyloid oligomers toxicity publication-title: J Alzheimer's Dis contributor: fullname: Lasagna-Reeves – volume: 19 start-page: 311 year: 2010 end-page: 323 ident: b0165 article-title: Alzheimer's disease and the amyloid-beta peptide publication-title: J Alzheimer's Dis contributor: fullname: LeVine – volume: 58 start-page: 1235 year: 2010 end-page: 1246 ident: b0175 article-title: Astrocytic A beta 1–42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins publication-title: Glia contributor: fullname: Veerhuis – volume: 6 start-page: 42 year: 2016 end-page: 49 ident: b0240 article-title: The role of amyloid-beta oligomers in toxicity, propagation, and immunotherapy publication-title: EBioMedicine contributor: fullname: Kayed – volume: 82 start-page: 1374 year: 2014 end-page: 1379 ident: b0060 article-title: Brain glucose transporters: implications for neurologic disease publication-title: Neurology contributor: fullname: Benarroch – volume: 15 start-page: 12323 year: 2014 ident: 10.1016/j.neuroscience.2017.03.059_b0180 article-title: Oleocanthal, a phenolic derived from virgin olive oil: a review of the beneficial effects on inflammatory disease publication-title: Int J Mol Sci doi: 10.3390/ijms150712323 contributor: fullname: Parkinson – volume: 6 start-page: 38187 year: 2016 ident: 10.1016/j.neuroscience.2017.03.059_b0095 article-title: Soluble amyloid-beta aggregates from human Alzheimer's disease brains publication-title: Sci Rep doi: 10.1038/srep38187 contributor: fullname: Esparza – volume: 9 start-page: 48 year: 2014 ident: 10.1016/j.neuroscience.2017.03.059_b0255 article-title: Oligomeric Abeta-induced synaptic dysfunction in Alzheimer's disease publication-title: Mol Neurodegeneration doi: 10.1186/1750-1326-9-48 contributor: fullname: Tu – volume: 11 start-page: 332 year: 2015 ident: 10.1016/j.neuroscience.2017.03.059_b0015 article-title: 2015 Alzheimer's disease facts and figures publication-title: Alzheimer's Dement doi: 10.1016/j.jalz.2015.02.003 contributor: fullname: Alzheimer's – volume: 690 start-page: 40 year: 2010 ident: 10.1016/j.neuroscience.2017.03.059_b0110 article-title: Activated astroglia during chronic inflammation in Alzheimer's disease–do they neglect their neurosupportive roles? publication-title: Mutat Res doi: 10.1016/j.mrfmmm.2009.08.016 contributor: fullname: Fuller – volume: 33 start-page: 5312 year: 2013 ident: 10.1016/j.neuroscience.2017.03.059_b0220 article-title: Amyloid-beta1-42 slows clearance of synaptically released glutamate by mislocalizing astrocytic GLT-1 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.5274-12.2013 contributor: fullname: Scimemi – volume: 20 start-page: 928 year: 1999 ident: 10.1016/j.neuroscience.2017.03.059_b0120 article-title: Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease publication-title: Electrophoresis doi: 10.1002/(SICI)1522-2683(19990101)20:4/5<928::AID-ELPS928>3.0.CO;2-Z contributor: fullname: Greber – volume: 6 start-page: 42 year: 2016 ident: 10.1016/j.neuroscience.2017.03.059_b0240 article-title: The role of amyloid-beta oligomers in toxicity, propagation, and immunotherapy publication-title: EBioMedicine doi: 10.1016/j.ebiom.2016.03.035 contributor: fullname: Sengupta – volume: 7 start-page: 549 year: 2014 ident: 10.1016/j.neuroscience.2017.03.059_b0100 article-title: Effects of APP 5-mer peptide analogue P165 on the synaptic proteins and insulin signal transduction proteins publication-title: Int J Clin Exp Med contributor: fullname: Feng – volume: 30 start-page: 408 year: 2008 ident: 10.1016/j.neuroscience.2017.03.059_b0140 article-title: Postsynaptic density protein PSD-95 expression in Alzheimer's disease and okadaic acid induced neuritic retraction publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2008.02.012 contributor: fullname: Leuba – volume: 223 start-page: 410 year: 2010 ident: 10.1016/j.neuroscience.2017.03.059_b0190 article-title: Soluble oligomeric forms of beta-amyloid (Abeta) peptide stimulate Abeta production via astrogliosis in the rat brain publication-title: Exp Neurol doi: 10.1016/j.expneurol.2009.10.013 contributor: fullname: Perez – volume: 58 start-page: 1235 year: 2010 ident: 10.1016/j.neuroscience.2017.03.059_b0175 article-title: Astrocytic A beta 1–42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins publication-title: Glia doi: 10.1002/glia.21004 contributor: fullname: Nielsen – volume: 75 start-page: 1076 year: 2000 ident: 10.1016/j.neuroscience.2017.03.059_b0185 article-title: The GLT-1 and GLAST glutamate transporters are expressed on morphologically distinct astrocytes and regulated by neuronal activity in primary hippocampal cocultures publication-title: J Neurochem doi: 10.1046/j.1471-4159.2000.0751076.x contributor: fullname: Perego – volume: 8 start-page: 7 year: 2016 ident: 10.1016/j.neuroscience.2017.03.059_b0020 article-title: SNAP-25, a known presynaptic protein with emerging postsynaptic functions publication-title: Front Syn Neurosci doi: 10.3389/fnsyn.2016.00007 contributor: fullname: Antonucci – volume: 4 start-page: 973 year: 2013 ident: 10.1016/j.neuroscience.2017.03.059_b0010 article-title: Olive-oil-derived oleocanthal enhances beta-amyloid clearance as a potential neuroprotective mechanism against Alzheimer's disease: in vitro and in vivo studies publication-title: ACS Chem Neurosci doi: 10.1021/cn400024q contributor: fullname: Abuznait – volume: 98 start-page: 29 year: 2016 ident: 10.1016/j.neuroscience.2017.03.059_b0085 article-title: Neuronal vs glial glutamate uptake: Resolving the conundrum publication-title: Neurochem Int doi: 10.1016/j.neuint.2016.05.009 contributor: fullname: Danbolt – volume: 17 start-page: 338 year: 2016 ident: 10.1016/j.neuroscience.2017.03.059_b0030 article-title: Amyloid-beta and astrocytes interplay in amyloid-beta related disorders publication-title: Int J Mol Sci doi: 10.3390/ijms17030338 contributor: fullname: Batarseh – volume: 32 start-page: 3081 year: 2012 ident: 10.1016/j.neuroscience.2017.03.059_b0125 article-title: Astrocyte-originated ATP protects Abeta(1–42)-induced impairment of synaptic plasticity publication-title: J Neurosci doi: 10.1523/JNEUROSCI.6357-11.2012 contributor: fullname: Jung – volume: 118 start-page: 103 year: 2009 ident: 10.1016/j.neuroscience.2017.03.059_b0050 article-title: Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer's disease publication-title: Acta Neuropathol doi: 10.1007/s00401-009-0522-3 contributor: fullname: Bell – volume: 7 start-page: 11761 year: 2016 ident: 10.1016/j.neuroscience.2017.03.059_b0040 article-title: Early detection of cryptic memory and glucose uptake deficits in pre-pathological APP mice publication-title: Nat Commun doi: 10.1038/ncomms11761 contributor: fullname: Beglopoulos – volume: 200 start-page: 629 year: 2002 ident: 10.1016/j.neuroscience.2017.03.059_b0005 article-title: Astrocyte-endothelial interactions and blood–brain barrier permeability publication-title: J Anat doi: 10.1046/j.1469-7580.2002.00064.x contributor: fullname: Abbott – volume: 110 start-page: 1339 year: 2009 ident: 10.1016/j.neuroscience.2017.03.059_b0150 article-title: Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau publication-title: J Neurochem doi: 10.1111/j.1471-4159.2009.06224.x contributor: fullname: Li – volume: 279 start-page: 40987 year: 2004 ident: 10.1016/j.neuroscience.2017.03.059_b0260 article-title: ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE publication-title: J Biol Chem doi: 10.1074/jbc.M407963200 contributor: fullname: Wahrle – volume: 53 start-page: 2442 year: 2014 ident: 10.1016/j.neuroscience.2017.03.059_b0170 article-title: Rare individual amyloid-beta oligomers act on astrocytes to initiate neuronal damage publication-title: Biochemistry doi: 10.1021/bi401606f contributor: fullname: Narayan – volume: 91 start-page: 1229 year: 2012 ident: 10.1016/j.neuroscience.2017.03.059_b0225 article-title: Further evidence for the anti-inflammatory activity of oleocanthal: inhibition of MIP-1alpha and IL-6 in J774 macrophages and in ATDC5 chondrocytes publication-title: Life Sci doi: 10.1016/j.lfs.2012.09.012 contributor: fullname: Scotece – volume: 437 start-page: 45 year: 2005 ident: 10.1016/j.neuroscience.2017.03.059_b0035 article-title: Phytochemistry: ibuprofen-like activity in extra-virgin olive oil publication-title: Nature doi: 10.1038/437045a contributor: fullname: Beauchamp – volume: 82 start-page: 4245 year: 1985 ident: 10.1016/j.neuroscience.2017.03.059_b0155 article-title: Amyloid plaque core protein in Alzheimer disease and Down syndrome publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.82.12.4245 contributor: fullname: Masters – volume: 19 start-page: 311 year: 2010 ident: 10.1016/j.neuroscience.2017.03.059_b0165 article-title: Alzheimer's disease and the amyloid-beta peptide publication-title: J Alzheimer's Dis doi: 10.3233/JAD-2010-1221 contributor: fullname: Murphy – volume: 286 start-page: 22122 year: 2011 ident: 10.1016/j.neuroscience.2017.03.059_b0135 article-title: Amyloid-beta annular protofibrils evade fibrillar fate in Alzheimer disease brain publication-title: J Biol Chem doi: 10.1074/jbc.M111.236257 contributor: fullname: Lasagna-Reeves – volume: 80 start-page: 1326 year: 2005 ident: 10.1016/j.neuroscience.2017.03.059_b0055 article-title: Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system publication-title: Mayo Clin Proc doi: 10.4065/80.10.1326 contributor: fullname: Benarroch – volume: 157–158 start-page: 423 year: 2005 ident: 10.1016/j.neuroscience.2017.03.059_b9000 article-title: ATP induces the post-synaptic gene expression in neuron-neuron synapses: Transcriptional regulation of AChE catalytic subunit publication-title: Chem-biol interact doi: 10.1016/j.cbi.2005.10.088 contributor: fullname: Siow – volume: 8 start-page: 67 year: 2011 ident: 10.1016/j.neuroscience.2017.03.059_b0145 article-title: Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease publication-title: Curr Alzheimer Res doi: 10.2174/156720511794604543 contributor: fullname: Li – volume: 277 start-page: 1348 year: 2010 ident: 10.1016/j.neuroscience.2017.03.059_b0215 article-title: Amyloid oligomers: formation and toxicity of Abeta oligomers publication-title: FEBS J doi: 10.1111/j.1742-4658.2010.07568.x contributor: fullname: Sakono – volume: 192 start-page: 106 year: 2008 ident: 10.1016/j.neuroscience.2017.03.059_b0235 article-title: Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior publication-title: Behav Brain Res doi: 10.1016/j.bbr.2008.02.016 contributor: fullname: Selkoe – volume: 11 start-page: 281 year: 2009 ident: 10.1016/j.neuroscience.2017.03.059_b0045 article-title: The role of astroglia in neuroprotection publication-title: Dial Clin Neurosci doi: 10.31887/DCNS.2009.11.3/mbelanger contributor: fullname: Belanger – volume: 81 start-page: 741 year: 2001 ident: 10.1016/j.neuroscience.2017.03.059_b0230 article-title: Alzheimer's disease: genes, proteins, and therapy publication-title: Physiol Rev doi: 10.1152/physrev.2001.81.2.741 contributor: fullname: Selkoe – volume: 11 start-page: e0155878 year: 2016 ident: 10.1016/j.neuroscience.2017.03.059_b0025 article-title: Low density lipoprotein-receptor related protein 1 is differentially expressed by neuronal and glial populations in the developing and mature mouse central nervous system publication-title: PLoS One doi: 10.1371/journal.pone.0155878 contributor: fullname: Auderset – volume: 26 start-page: 230 year: 2014 ident: 10.1016/j.neuroscience.2017.03.059_b0070 article-title: PACAP protects against inflammatory-mediated toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease publication-title: Neurotox Res doi: 10.1007/s12640-014-9468-x contributor: fullname: Brown – volume: 82 start-page: 1374 year: 2014 ident: 10.1016/j.neuroscience.2017.03.059_b0060 article-title: Brain glucose transporters: implications for neurologic disease publication-title: Neurology doi: 10.1212/WNL.0000000000000328 contributor: fullname: Benarroch – volume: 240 start-page: 189 year: 2009 ident: 10.1016/j.neuroscience.2017.03.059_b0195 article-title: Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal publication-title: Toxicol Appl Pharmacol doi: 10.1016/j.taap.2009.07.018 contributor: fullname: Pitt – volume: 102 start-page: 812 year: 2007 ident: 10.1016/j.neuroscience.2017.03.059_b0080 article-title: Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells publication-title: J Neurochem doi: 10.1111/j.1471-4159.2007.04533.x contributor: fullname: Cobos – volume: 39 start-page: 84 year: 2017 ident: 10.1016/j.neuroscience.2017.03.059_b0105 article-title: High concentration of trichlorfon (1mM) disrupts axonal cytoskeleton and decreases the expression of plasticity-related proteins in SH-SY5Y cells publication-title: Toxicol In Vitro doi: 10.1016/j.tiv.2016.12.003 contributor: fullname: Fernandes – volume: 12 start-page: 784 year: 2016 ident: 10.1016/j.neuroscience.2017.03.059_b0245 article-title: Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease publication-title: Autophagy doi: 10.1080/15548627.2016.1159375 contributor: fullname: Son – start-page: 371 year: 2016 ident: 10.1016/j.neuroscience.2017.03.059_b0075 article-title: Impairments of neural circuit function in Alzheimer's disease publication-title: Philo Trans R Soc Lond Ser B contributor: fullname: Busche – volume: 79 start-page: 668 year: 2014 ident: 10.1016/j.neuroscience.2017.03.059_b0200 article-title: Differences in amyloid-beta clearance across mouse and human blood–brain barrier models: kinetic analysis and mechanistic modeling publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2014.01.023 contributor: fullname: Qosa – volume: 9 start-page: 453 year: 2003 ident: 10.1016/j.neuroscience.2017.03.059_b0265 article-title: Adult mouse astrocytes degrade amyloid-beta in vitro and in situ publication-title: Nat Med doi: 10.1038/nm838 contributor: fullname: Wyss-Coray – volume: 33 start-page: S67 issue: Suppl 1 year: 2013 ident: 10.1016/j.neuroscience.2017.03.059_b0130 article-title: Molecular mechanisms of amyloid oligomers toxicity publication-title: J Alzheimer's Dis contributor: fullname: Kayed – volume: 38 start-page: 3751 year: 1978 ident: 10.1016/j.neuroscience.2017.03.059_b0065 article-title: Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones publication-title: Cancer Res contributor: fullname: Biedler – volume: 6 start-page: 1849 year: 2015 ident: 10.1016/j.neuroscience.2017.03.059_b0205 article-title: Oleocanthal enhances amyloid-beta clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model publication-title: ACS Chem Neurosci doi: 10.1021/acschemneuro.5b00190 contributor: fullname: Qosa – volume: 3 start-page: 269 year: 2012 ident: 10.1016/j.neuroscience.2017.03.059_b0250 article-title: LRP-1 and LRP-2 receptors function in the membrane neuron. Trafficking mechanisms and proteolytic processing in Alzheimer's disease publication-title: Front Physiol doi: 10.3389/fphys.2012.00269 contributor: fullname: Spuch – volume: 122 start-page: 1131 year: 1984 ident: 10.1016/j.neuroscience.2017.03.059_b0115 article-title: Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein publication-title: Biochem Biophys Res Commun doi: 10.1016/0006-291X(84)91209-9 contributor: fullname: Glenner – volume: 98 start-page: 19 year: 2016 ident: 10.1016/j.neuroscience.2017.03.059_b0210 article-title: GLT-1: the elusive presynaptic glutamate transporter publication-title: Neurochem Int doi: 10.1016/j.neuint.2016.04.010 contributor: fullname: Rimmele |
SSID | ssj0000543 |
Score | 2.4894538 |
Snippet | Highlights • Oleocanthal rectified Aβo-induced pathological changes in astrocytes and neurons in-vitro. • Oleocanthal reduced astrocytes activation and... •Oleocanthal rectified Aβo-induced pathological changes in astrocytes and neurons in vitro.•Oleocanthal reduced astrocyte activation and inflammation... Extra-virgin olive oil (EVOO) has several health promoting effects. Evidence have shown that EVOO attenuates the pathology of amyloid-β (Aβ) and improves... |
SourceID | pubmedcentral crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 204 |
SubjectTerms | Aldehydes - pharmacology Amyloid beta-Peptides - toxicity Amyloid beta-Protein Precursor - genetics Amyloid beta-Protein Precursor - metabolism amyloid-β Anti-Inflammatory Agents - pharmacology astrocytes Astrocytes - drug effects Cell Line, Tumor Disks Large Homolog 4 Protein - metabolism Dose-Response Relationship, Drug Glutamate Plasma Membrane Transport Proteins - metabolism Humans Interleukin-6 - metabolism Nerve Tissue Proteins - metabolism neuroinflammation Neurology neurons Neurons - drug effects oleocanthal Phenols - pharmacology Synaptosomal-Associated Protein 25 - metabolism Time Factors Transfection |
Title | Oleocanthal Ameliorates Amyloid-β Oligomers Toxicity on Astrocytes and Neuronal Cells: In-vitro Studies |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0306452217302348 https://dx.doi.org/10.1016/j.neuroscience.2017.03.059 https://www.ncbi.nlm.nih.gov/pubmed/28392295 https://pubmed.ncbi.nlm.nih.gov/PMC5504696 |
Volume | 352 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NTtwwELYQvfSCoJSy_UE-VNzCJrGTrCv1sEJFSxFwaJG4WY5_IHQ3QU2oyqXqa_Q1-iB9iD5JZ5xk2RWHInFKnIxlxzO2Pzsznwl5G-nUMeS3U8aagBubBLmxKnCaCyW4y6MQo5GPT9LJGf94npyvkP0-FgbdKruxvx3T_WjdPRl2rTm8LorhJ0S7yAceZXjwDceAX0hi59z7cefmAZCkPSIZVs4o3ROPeh-vBc5IpMyMMk94iryl_5mklh0oF2akg3Wy1kFJOm5ru0FWbPmMbI5LWEbPbuku9c6dftd8k3w5ndoKW_EScqiZnWJkPqBMuIcVe2GCP79pNS0uKtzG_vvzF22q74UGhE6rkqq6gWnu1ouXhvrPwZJx079-Rw9L-q0ACVq3PonPydnBh8_7k6A7ZyHQCY-bYIQgTbs4cU6IJB8xlnKljQ0VkvWpTCeAU5LchSzOspxDn7VRagBpabgwbdgWWS2r0m4TCu3tUm0BV-If1UzkIlJaOKtCo0cjkQ4I6xtWXrd0GrL3M7uSi-qQqA4ZMgnqGJCs14HsA0ZhiLN1199qGck6lqG8ZxMD8n6ec8msJMwYDyr5RavpeW1jRJSxSKBOSzYwF0C-7uU3ZXHpebthMchTkb58ZJ1ekaeY8v5q7DVZbb7e2DeAjJp8x5v-DnkyPjyanPwDw8YVRA |
link.rule.ids | 230,315,786,790,891,4521,24144,27957,27958,45620,45714 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwELZKOcAFUQp0CwUfELewSez8GIlDVbXaQlsOtFJvluOfNmWbVE1A9FL1NXgNHoSH4Ek64yTLrjiAxClRPFacGf98dma-IeRVpFPHkN9OGWsCbmwSFMaqwGkulOCuiEKMRt4_SCdH_P1xcrxEtoZYGHSr7Of-bk73s3X_ZNxrc3xRluNPiHaRDzzKMPENz--QuwjnMX_Dm-vffh6ASbocybB1RvGBedQ7ec2RRiJnZpR5xlMkLv3LKrXoQTm3JO08JA96LEk3u-aukCVbPSKrmxXso8-v6GvqvTv9sfkq-fxxamtU4ynUUOd2iqH5ADPhHrbspQl-_qD1tDyp8Rz718132tbfSg0QndYVVU0L69yVF68M9Z-Db8ZT_-Yt3a3o1xIkaNM5JT4mRzvbh1uToE-0EOiEx22QI0rTLk6cEyIpcsZSrrSxoUK2PpXpBIBKUriQxVlWcBi0NkoNQC0NF6YNe0KWq7qya4SCvl2qLQBL_KWaiUJESgtnVWh0not0RNigWHnR8WnIwdHsTM6bQ6I5ZMgkmGNEssEGcogYhTnONv2Aa2Qkm1iG8o9OMSLvZjUX-pWEJeOf3vy0s_SstTFCylgk0KaFPjATQMLuxZKqPPXE3bAb5KlI1_-zTS_Jvcnh_p7c2z348IzcxxLvvMaek-X28ovdAJjUFi_8MLgF-CsW1g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oleocanthal+ameliorates+amyloid-%CE%B2+oligomers%27+toxicity+on+astrocytes+and+neuronal+cells%3A+In+vitro+studies&rft.jtitle=Neuroscience&rft.au=Batarseh%2C+Yazan+S&rft.au=Mohamed%2C+Loqman+A&rft.au=Al+Rihani%2C+Sweilem+B&rft.au=Mousa%2C+Youssef+M&rft.date=2017-06-03&rft.eissn=1873-7544&rft.volume=352&rft.spage=204&rft_id=info:doi/10.1016%2Fj.neuroscience.2017.03.059&rft_id=info%3Apmid%2F28392295&rft.externalDocID=28392295 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0306-4522&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0306-4522&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0306-4522&client=summon |